Back
Direxion Daily Gold Miners Bull 2X ETF Vs. Spyre Therapeutics Industry Stock Comparison
Sell
45
NUGT
Direxion Daily Gold Miners Bull 2X ETF
Last Price:
36.31
Seasonality Move:
-2.85%
Sell
39
SYRE
Spyre Therapeutics
Last Price:
25.33
Seasonality Move:
49.76%
Sell
45
Direxion Daily Gold Miners Bull 2X ETF (NUGT)
is a Sell
Is Direxion Daily Gold Miners Bull 2X ETF a Buy, Sell or Hold?
- The current Direxion Daily Gold Miners Bull 2X ETF [NUGT] share price is $36.29. The Score for NUGT is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- NUGT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Spyre Therapeutics (SYRE)
is a Sell
Is Spyre Therapeutics a Buy, Sell or Hold?
- The current Spyre Therapeutics [SYRE] share price is $25.43. The Score for SYRE is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- SYRE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NUGT Stock Price Chart
What is Direxion Daily Gold Miners Bull 2X ETF's stock price today?
-
The Direxion Daily Gold Miners Bull 2X ETF share price today is $36.29
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NUGT is experiencing slight buying pressure.
SYRE Stock Price Chart
What is Spyre Therapeutics's stock price today?
-
The Spyre Therapeutics share price today is $25.43
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SYRE is experiencing selling pressure, which indicates risk of future bearish movement.
NUGT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.01 | Sell |
Relative Strength Index (14 RSI): | 41.23 | Sell |
Chaikin Money Flow: | 598655 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (38.07 - 43.87) | Sell |
Bollinger Bands (100): | (28.12 - 40.84) | Buy |
SYRE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.04 | Sell |
Relative Strength Index (14 RSI): | 31.35 | Sell |
Chaikin Money Flow: | -1780910 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (32.05 - 37.75) | Sell |
Bollinger Bands (100): | (27.4 - 39.18) | Sell |
NUGT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 37.9 | Sell |
20-day SMA: | 40.47 | Sell |
50-day SMA: | 39.96 | Sell |
200-day SMA: | 32.65 | Buy |
8-day EMA: | 37.7 | Sell |
20-day EMA: | 39.27 | Sell |
50-day EMA: | 38.73 | Sell |
200-day EMA: | 35 | Buy |
SYRE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 33.63 | Sell |
20-day SMA: | 34.16 | Sell |
50-day SMA: | 35.1 | Sell |
200-day SMA: | 24.22 | Buy |
8-day EMA: | 32.34 | Sell |
20-day EMA: | 33.91 | Sell |
50-day EMA: | 34.32 | Sell |
200-day EMA: | 27.18 | Sell |
Direxion Daily Gold Miners Bull 2X ETF Earnings Growth & NUGT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Spyre Therapeutics Earnings Growth & SYRE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.10 per share, an increase this year of $9.41 per share, and an increase next year of $0.45 per share.
Direxion Daily Gold Miners Bull 2X ETF Technical Analysis
Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Spyre Therapeutics Technical Analysis
Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |